Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review
- PMID: 30182306
- DOI: 10.1007/s00595-018-1710-3
Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review
Abstract
Purpose: To investigate the recent Japanese prevalence of thyroid cancer and its characteristics in familial adenomatous polyposis (FAP) patients, through the development of surveillance programs.
Methods: The subjects of this study were 282 (93.1%) FAP patients for whom information on thyroid cancer was available, from among 303 patients registered in "the Retrospective Cohort Study of Familial Adenomatous Polyposis in Japan" database. We evaluated the prevalence and risk factors for thyroid cancer and integrated and/or compared our findings with those of previous reports, using a systematic review, including a meta-analysis.
Results: Thyroid cancer was diagnosed in 16 women (11.4%) and 2 men (1.4%), at 17-41 years and 39-57 years of age, respectively. The prevalence of thyroid cancer was 6.4%, with a female-to-male ratio of 8:1, which is comparable to reports from other countries. A young age of < 33 years at the FAP diagnosis and female gender were identified as independent risk factors for thyroid cancer.
Conclusions: FAP-associated thyroid cancer predominantly affects young women, both in Japan and other countries. Since FAP is generally diagnosed when patients are in their 20 s or older, regular screening for thyroid cancer is recommended for all FAP patients, but especially women, from their early 20 s.
Keywords: Familial adenomatous polyposis; Meta-analysis; Prevalence; Risk factor; Thyroid cancer.
Similar articles
-
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.Fam Cancer. 2016 Apr;15(2):267-74. doi: 10.1007/s10689-015-9862-4. Fam Cancer. 2016. PMID: 26690363 Free PMC article.
-
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.Clin Colorectal Cancer. 2012 Dec;11(4):304-8. doi: 10.1016/j.clcc.2012.01.006. Epub 2012 Mar 15. Clin Colorectal Cancer. 2012. PMID: 22425061
-
Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis.Fam Cancer. 2019 Jan;18(1):53-62. doi: 10.1007/s10689-018-0085-3. Fam Cancer. 2019. PMID: 29663106
-
Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.J Clin Endocrinol Metab. 2016 Dec;101(12):4611-4617. doi: 10.1210/jc.2016-2043. Epub 2016 Sep 13. J Clin Endocrinol Metab. 2016. PMID: 27623068
-
A distinct variant of papillary thyroid carcinoma indicating familial adenomatous polyposis (FAP): a case report and brief review.BMC Res Notes. 2015 Dec 17;8:795. doi: 10.1186/s13104-015-1736-1. BMC Res Notes. 2015. PMID: 26681171 Free PMC article. Review.
Cited by
-
The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.Cancer Rep (Hoboken). 2023 Jan;6(1):e1652. doi: 10.1002/cnr2.1652. Epub 2022 Jun 12. Cancer Rep (Hoboken). 2023. PMID: 35691611 Free PMC article.
-
Gastrointestinal Polyposis in Pediatric Patients.J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):273-280. doi: 10.1097/MPG.0000000000002421. J Pediatr Gastroenterol Nutr. 2019. PMID: 31211762 Free PMC article. Review.
-
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.Br J Surg. 2024 May 3;111(5):znae070. doi: 10.1093/bjs/znae070. Br J Surg. 2024. PMID: 38722804 Free PMC article.
-
Long-term clinical outcomes and follow-up status in Japanese patients with familial adenomatous polyposis after radical surgery: a descriptive, retrospective cohort study from a single institute.Int J Colorectal Dis. 2020 Apr;35(4):675-684. doi: 10.1007/s00384-020-03524-y. Epub 2020 Feb 7. Int J Colorectal Dis. 2020. PMID: 32034491
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous